Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Malignant neuroleptic syndrome]

A Segado Soriano1, C López Gonzalez-Cobos, M V Villalba Garciá

  • 1Departamento de Urgencia, Hospital General Universitario Gregorio Marañón, Madrid.

Anales De Medicina Interna (Madrid, Spain : 1984)
|May 1, 1997
PubMed
Summary

Neuroleptic Malignant Syndrome (NMS) is a rare but serious condition. Early recognition and intensive treatment are crucial for improving patient outcomes and reducing mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Which one is a better predictor of prognosis in COVID-19: analytical biomarkers or PaO2/FiO2?

Revista clinica espanola·2024
Same author

[Patients with COPD hospitalized due to COVID-19 in Spain: a comparison between the first and second wave].

Revista clinica espanola·2023
Same author

[Impact of days elapsed from the onset of symptoms to hospitalization in COVID-19 in-hospital mortality: Time matters].

Revista clinica espanola·2023
Same author

Patients with COPD hospitalized due to COVID-19 in Spain: a comparison between the first and second wave.

Revista clinica espanola·2023
Same author

Impact of days elapsed from the onset of symptoms to hospitalization in COVID-19 in-hospital mortality: time matters.

Revista clinica espanola·2023
Same author

[Management of hypertension and diabetes in Primary Care clinical practice: ATENCION study].

Semergen·2016

Area of Science:

  • Neuroscience
  • Pharmacology
  • Critical Care Medicine

Context:

  • Neuroleptic Malignant Syndrome (NMS) is a rare, life-threatening condition.
  • It is associated with antipsychotic medication use.
  • Characterized by hyperthermia, autonomic instability, and muscle rigidity.

Purpose:

  • To describe the clinical characteristics of NMS in ten patients.
  • To identify risk factors and outcomes associated with NMS.
  • To emphasize the importance of early diagnosis and treatment.

Summary:

  • Ten patients diagnosed with NMS were analyzed.
  • The majority of cases (90%) involved Haloperidol.
  • Mortality was 20%, often linked to respiratory failure and delayed ICU admission.

Related Experiment Videos

Impact:

  • Highlights the critical need for a high index of suspicion for NMS.
  • Underscores the importance of prompt and intensive medical intervention.
  • Informs clinical practice regarding NMS management and patient outcomes.